SGLT2 inhibitor
A class of drugs used to lower glucose levels, part of the strategy to target glucose in cancer metabolic therapy.
Save the 4 videos on SGLT2 inhibitor to your own pod.
Sign up free to keep building your knowledge base on SGLT2 inhibitor as more episodes are added.
Videos Mentioning SGLT2 inhibitor
#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP
Peter Attia MD
A class of drugs including canagliflozin, used for type 2 diabetes, which block glucose reuptake in the kidney. ITP results show it extends lifespan in male mice, possibly by reducing peak glucose levels.
375 - The ketogenic diet, ketosis, and hyperbaric oxygen: weight loss, cognition, cancer, and more
Peter Attia MD
A class of drugs used to lower glucose levels, part of the strategy to target glucose in cancer metabolic therapy.
Supplements for Longevity & Their Efficacy | Dr. Peter Attia
Andrew Huberman
A class of medication, including Canagliflozin, taken by Peter Attia and discussed for its broad geroprotective effects, particularly influencing glucose regulation.
216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
Peter Attia MD
A type of medication being investigated in a clinical trial combined with a low-carbohydrate diet to induce ketosis in cancer patients.